Literature DB >> 10585366

Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: detection of the rare allele CYP2C19*4.

M Garcia-Barceló1, L Y Chow, H F Kum Chiu, Y K Wing, D T Shing Lee, K L Lam, M M Waye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10585366

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  9 in total

1.  The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.

Authors:  J Rosemary; C Adithan; N Padmaja; C H Shashindran; N Gerard; R Krishnamoorthy
Journal:  Eur J Clin Pharmacol       Date:  2005-01-21       Impact factor: 2.953

2.  Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Authors:  S A Scott; S Martis; I Peter; Y Kasai; R Kornreich; R J Desnick
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

3.  CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.

Authors:  Sze Wa Chan; Miao Hu; Sara Shun Wah Ko; Catherine Wing Yan Tam; Benny Siu Pong Fok; Ophelia Qi Ping Yin; Moses Sing Sum Chow; Brian Tomlinson
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

Review 4.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

5.  Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.

Authors:  Heydy V Bravo-Villalta; Koujirou Yamamoto; Katsunori Nakamura; Ana Bayá; Yuko Okada; Ryuya Horiuchi
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

Review 6.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 7.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

8.  The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.

Authors:  Ren-Ai Xu; Er-Min Gu; Teng-Hui Liu; Qiu-Geng Ou-Yang; Guo-Xin Hu; Jian-Ping Cai
Journal:  Infect Drug Resist       Date:  2018-11-01       Impact factor: 4.003

9.  Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.

Authors:  Carlos Isaza; Julieta Henao; José H Isaza Martínez; Juan C Sepúlveda Arias; Leonardo Beltrán
Journal:  BMC Clin Pharmacol       Date:  2007-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.